Articles On Elixinol Global (ASX:EXL)

Title Source Codes Date
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

Stockhead EXL 4 days ago
Elixinol Global sees steady improvements in first quarter revenue as UK COVID restrictions ease and US stimulus packages take effect

Its lead indicators for the current quarter are looking positive as the UK comes out of a hard lockdown and customers have started placing replenishment orders.

Proactive Investors EXL 1 week ago
Elixinol (ASX:EXL) share price heats up on cannabis business update

The Elixinol Global Ltd (ASX: EXL) share price is rising today after the company released its quarterly activity update. At the time of writing, the Elixinol share price is up 5.88% to 18 cents per share. Elixinol’s focus is the manufactur...

Motley Fool EXL 2 weeks ago
Weed Week: 4/20 can’t help ASX cannabis companies

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

Stockhead EXL 2 weeks ago
Hidden Gems Webinar Recap – PFG, EXL, MX1, BRU

ShareCafeHidden Gems Webinar Recap – PFG, EXL, MX1, BRU Catch up on the full webinar with a keynote presentation from Prime Financial Group (ASX: PFG), Elixinol Global (ASX: EXL), Micro-X (ASX: MX1) & Buru Energy (ASX: BRU) Hidden Gems...

ShareCafe EXL 3 weeks ago
Elixinol Global (ASX: EXL) – Hidden Gems Webinar Presentation 

ShareCafeElixinol Global (ASX: EXL) – Hidden Gems Webinar Presentation  Presenter – Oliver Horn – Executive Director & Global Chief Executive Officer – Elixinol Global Limited is a global leader in the hemp-derived CBD industry, resear...

ShareCafe EXL 3 weeks ago
Weed Week: Australian medical cannabis prescriptions are soaring

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

Stockhead EXL 1 month ago
Here’s why ASX cannabis shares are lighting up today

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...

Motley Fool EXL 1 month ago
Weed Week: Oz cannabis revenue expected to double in 2021 as patients soar

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

Stockhead EXL 1 month ago
Last Orders: ASX finishes up despite investors jumping off Airtasker float

The ASX finished the day slightly in the green, dragged down by tech stocks which lost nearly 1.5 per cent and new float Airtasker (ASX:ART) fell by over 20 per cent. Airtasker debuted at 65 cents and rose over Tuesday and Wednesday to over...

Stockhead EXL 1 month ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead EXL 1 month ago
Weed Week: US pot legalisation picks up steam, and the Big Apple could be next

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...

Stockhead EXL 1 month ago
Elixinol Share Price Up 12% after Acquiring CannaCare Health (ASX:EXL)

Elixinol Global Ltd [ASX:EXL] share price is up today after agreeing to acquire Germany's leading CBD brand. The EXL share price is now up 25% YTD, but still down from the 52-week high of 47.5 cents. The post Elixinol Share Price Up 12% af...

MoneyMorning EXL 1 month ago
Elixinol to bag German CBD brand for $13.9m

Australian cannabis company Elixinol's (ASX: EXL) plans to push further into Europe will be accelerated via the proposed nine million-euro (AUD$13.9 million) acquisition of a leading German CBD brand. The deal will see Elixinol acquire Ca...

businessnewsaustralia.com EXL 1 month ago
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board

Elixinol (ASX:EXL) has become the latest cannabis stock to get into the M&A game, acquiring German company CannaCare. CannaCare is ... Read More The post Elixinol the latest pot stock to M&A; recruits German media entrepreneur to it...

Stockhead EXL 1 month ago
Why the Elixinol (ASX:EXL) share price has been halted today?

The Elixinol Global Ltd (ASX: EXL) share price has been halted today as the company reported that it would be announcing a potential transaction. Shares in the small-cap cannabis company have not been trading since the start of today. Cons...

Motley Fool EXL 2 months ago
Elixinol Global in trading halt with potential transaction news pending

Under new group leadership, Elixinol’s business has been substantially repositioned to be more focused with substantial cost reductions and improved cashflows.

Proactive Investors EXL 2 months ago
Elixinol Global accelerates growth strategy following global re-set of initiatives

Elixinol is now in an enviable position to be able to create a sustainable global consumer goods business with a purpose.

Proactive Investors EXL 2 months ago
Elixinol Global substantial holder Regal Funds Management increases stake

The company recently increased its share purchase plan from the initial A$2 million target to around A$12.3 million to accommodate strong shareholder demand.

Proactive Investors EXL 3 months ago
Up in smoke! Why ASX cannabis shares are having a bleary day

Not too many investors are having a good time today. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is down 2.18% to 6,633points, snapping the healthy momentum that 2021 had brought until now. One ASX sector is fairing a lot...

Motley Fool EXL 3 months ago
Lifespot Health reveals investment from major Canadian cannabis fund

Lifespot Health (ASX: LSH) has announced a significant investment by major Canadian cannabis investment fund Ela Capital, marking a great achievement for the Australian cannabis industry as well as providing the necessary boost for the acce...

SmallCaps EXL 3 months ago
Why Elixinol Global, Flight Centre, Mesoblast, & WiseTech shares are dropping lower

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is down 0.55% to 6,638.5 points at the time of writing. Four shares that have fallen more than most to...

Motley Fool EXL 4 months ago
Why the Elixinol Global (ASX:EXL) share price is getting smoked today

Elixinol Global Ltd (ASX: EXL) shares are plummeting today, going for just 18.5 cents a share at the time of writing, down 11.09%. The Elixinol share price closed at 21 cents on Friday and opened at 19 cents this morning before dropping to...

Motley Fool EXL 4 months ago
Elixinol Global directors participate in $12.3 million share purchase plan

The company recently increased its share purchase plan (SPP) from the initial $2 million target to around $12.3 million to accommodate strong shareholder demand after it was significantly oversubscribed.

Proactive Investors EXL 4 months ago
27 ASX companies just got an unwanted knock on the door

The corporate regulator has revealed it’s had to make enquiries with 27 ASX listed companies about their 2020 financial reports. The Australian Securities and Investments Commission (ASIC) announced Thursday that it had reviewed financial...

Motley Fool EXL 4 months ago
Elixinol Global delighted as demand for its share purchase plan far exceeds target

Proactive Investors EXL 4 months ago
Elixinol Global boosts A$2 million SPP to around A$12.3 million after fielding subscriptions totalling A$27.2 million

“To exceed our SPP target is a very strong signal that our shareholders have the confidence in our business outlook," says CEO

Proactive Investors EXL 4 months ago
Elixinol Global well-positioned for growth on back of positive cannabis regulatory decisions

The company is submitting a Novel Foods application in Europe, expanding its CBD product range across the US given an increasingly favourable regulatory outlook and continuing the growth of its market-leading Hemp Foods Australia brand.

Proactive Investors EXL 5 months ago
Elixinol (ASX:EXL) share price tumbles on capital raising update

The Elixinol Global Ltd (ASX: EXL) share price tumbled after management issued an update to its share purchase plan (SPP) today. The EXL share price lost 7.6% to 24 cents in after lunch trade when the S&P/ASX 200 Index (Index:^AXJO) ga...

Motley Fool EXL 5 months ago
Elixinol Global's share purchase plan receives strong early support with take up of more than 65% so far

The company has received applications in excess of A$1.3 million of the A$2 million SPP target.

Proactive Investors EXL 5 months ago
Why the Elixinol (ASX:EXL) share price popped 43% today

The Elixinol Global Ltd (ASX: EXL) share price soared today, after it was announced that the United Nations (UN) has rescheduled its classification of cannabis. According to the company, this is expected to favourably impact its global bus...

Motley Fool EXL 5 months ago
Elixinol Global buoyed by United Nations reclassification of cannabis as less dangerous drug

This UN decision, which acknowledges medicinal usefulness of cannabis and clarifies that CBD is not under international drug control, is expected to have a substantial impact on Elixinol’s ability to drive product sales in Europe and other...

Proactive Investors EXL 5 months ago
Elixinol Global welcomes strong support for $8.2 million fundraise to accelerate growth strategy

Proactive Investors EXL 5 months ago
CBD oil products biz taps MST Financial for raising

CBD hemp oil products maker Elixinol Global landed in front of small cap fund managers on Friday morning, seeking an equity injection.

AFR EXL 5 months ago
ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs

The Elixinol Global Ltd (ASX: EXL) share price is on fire today, up more than 55% at the time of writing to 22 cents a share. The Elixinol share price closed at 14 cents a share last week, but opened this morning at 16 cents a share and ha...

Motley Fool EXL 6 months ago
Elixinol Share Price Gets Small Boost on Turnaround (ASX:EXL)

After a ripper period in early 2019, the Elixinol Global Ltd [ASX:EXL] share price went on a long-term slide. On a day where the EXL share price was up 3.33% to trade at 15.5 cents, we take a look at the numbers from EXL quarterly update......

MoneyMorning EXL 6 months ago
Pot stocks look to launch new products following yesterday’s TGA ruling

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

Stockhead EXL 8 months ago
Elixinol secures foothold in Australian market with PharmaCann agreement

Elixinol (ASX: EXL) will finally be able to sell its CBD products in Australia after penning an exclusive distribution agreement with licenced wholesaler PharmaCann. Under the agreement PharmaCann will import and supply Elixinol's branded...

BusinessNewsAus EXL 9 months ago
Which stocks could be hit by tax loss selling as end of financial year looms?

With less than a month to go of the 2019-20 financial year, time is running out for share market investors to minimise their tax bill. One way is by selling stocks investors have made a loss on and claiming them as an offset against any cap...

Stockhead EXL 11 months ago
Weed Week: Cannabis for kids? UK baby participates in world-first treatment

For the many companies in Australia’s medicinal cannabis sector, the health benefits of cannabidiol (CBD) products are self-evident. But a trial underway in the UK is also testing the safety and efficiency of cannabis-derived medicines to t...

Stockhead EXL 11 months ago
Should you ever buy into an ASX IPO?

An IPO (or Initial Public Offering) can be an exciting event on the ASX, or any other share market for that matter. That’s because it involves the process of a private company becoming public, with its shares trading on the stock exchange...

Motley Fool EXL 11 months ago
THC Global starts sales as one of few pot stocks making Aussie-grown marijuana

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

Stockhead EXL 11 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Thursday, May 14. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

Stockhead EXL 11 months ago
10 at 10: These ASX stocks are flexing their muscles this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead EXL 11 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Tuesday, May 12. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

Stockhead EXL 11 months ago
ASX companies needing capital urged to ‘act now’ before funding dries up

A fair chunk of ASX-listed companies have had little difficulty in raising capital recently, but the good run won’t last forever. In April, small caps with market capitalisations between $100m and $500m raised $583m while micro-caps worth l...

Stockhead EXL 11 months ago
10 at 10: These ASX stocks are brewing a storm this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead EXL 11 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Monday, May 11. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   WINNERS CODE NAME PRICE...

Stockhead EXL 11 months ago
Why Elixinol Global, National Storage, Qantas, & Vicinity shares are dropping lower

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is off its low but remains on course to end its winning streak. The benchmark index is down 0.75% to 5,367.3 points at the time of writing. Four shares falling more than most today ar...

Motley Fool EXL 1 year ago
TGA may make CBD legal in pharmacies this year

The Australian drugs regulator is weighing whether to allow cannabidiol-only (CBD) products to be sold over the counter in pharmacies, bringing it into line with other countries where medical marijuana is legal. The Therapeutic Drug Adminis...

Stockhead EXL 1 year ago